
Sign up to save your podcasts
Or


This week on BioTech Nation, Bruin Biometrics CEO Martin Burns talks about a new diagnostic tool being used to detect and prevent potentially fatal bedsores in their earliest stages.
By Moira Gunn4.1
2929 ratings
This week on BioTech Nation, Bruin Biometrics CEO Martin Burns talks about a new diagnostic tool being used to detect and prevent potentially fatal bedsores in their earliest stages.

21,974 Listeners

43,864 Listeners

32,020 Listeners

30,707 Listeners

43,579 Listeners

707 Listeners

6,420 Listeners

30,216 Listeners

125 Listeners

321 Listeners

9,911 Listeners

34 Listeners

18 Listeners

48 Listeners

138 Listeners